Wells Fargo’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587 | Sell |
524
-7,084
| -93% | -$7.94K | ﹤0.01% | 5898 |
|
|
2025
Q1 | $8.75K | Buy |
7,608
+164
| +2% | +$189 | ﹤0.01% | 5448 |
|
|
2024
Q4 | $45.5K | Buy |
7,444
+2,457
| +49% | +$15K | ﹤0.01% | 5025 |
|
|
2024
Q3 | $82.5K | Sell |
4,987
-146
| -3% | -$2.42K | ﹤0.01% | 4732 |
|
|
2024
Q2 | $35.3K | Buy |
5,133
+294
| +6% | +$2.02K | ﹤0.01% | 5048 |
|
|
2024
Q1 | $46.7K | Buy |
4,839
+604
| +14% | +$5.83K | ﹤0.01% | 4903 |
|
|
2023
Q4 | $35.2K | Buy |
4,235
+1,134
| +37% | +$9.42K | ﹤0.01% | 4978 |
|
|
2023
Q3 | $25.9K | Sell |
3,101
-1,547
| -33% | -$12.9K | ﹤0.01% | 5133 |
|
|
2023
Q2 | $42.9K | Buy |
4,648
+2,529
| +119% | +$23.3K | ﹤0.01% | 5202 |
|
|
2023
Q1 | $29.1K | Buy |
2,119
+1,994
| +1,595% | +$27.4K | ﹤0.01% | 5155 |
|
|
2022
Q4 | $2.13K | Sell |
125
-284
| -69% | -$4.83K | ﹤0.01% | 5675 |
|
|
2022
Q3 | $9K | Sell |
409
-12
| -3% | -$264 | ﹤0.01% | 5395 |
|
|
2022
Q2 | $7K | Buy |
421
+296
| +237% | +$4.92K | ﹤0.01% | 5593 |
|
|
2022
Q1 | $3K | Sell |
125
-3,795
| -97% | -$91.1K | ﹤0.01% | 6225 |
|
|
2021
Q4 | $115K | Sell |
3,920
-4,181
| -52% | -$123K | ﹤0.01% | 5167 |
|
|
2021
Q3 | $533K | Sell |
8,101
-12,235
| -60% | -$805K | ﹤0.01% | 4365 |
|
|
2021
Q2 | $1.69M | Buy |
20,336
+7,120
| +54% | +$592K | ﹤0.01% | 3635 |
|
|
2021
Q1 | $1.01M | Sell |
13,216
-8,380
| -39% | -$642K | ﹤0.01% | 3978 |
|
|
2020
Q4 | $1.91M | Buy |
21,596
+13,990
| +184% | +$1.24M | ﹤0.01% | 3490 |
|
|
2020
Q3 | $561K | Sell |
7,606
-3,034
| -29% | -$224K | ﹤0.01% | 4155 |
|
|
2020
Q2 | $776K | Sell |
10,640
-5,503
| -34% | -$401K | ﹤0.01% | 3905 |
|
|
2020
Q1 | $906K | Buy |
16,143
+13,531
| +518% | +$759K | ﹤0.01% | 3508 |
|
|
2019
Q4 | $99K | Buy |
+2,612
| New | +$99K | ﹤0.01% | 5089 |
|